Engineering targeted viral vectors for gene therapy

Nat Rev Genet. 2007 Aug;8(8):573-87. doi: 10.1038/nrg2141. Epub 2007 Jul 3.


To achieve therapeutic success, transfer vehicles for gene therapy must be capable of transducing target cells while avoiding impact on non-target cells. Despite the high transduction efficiency of viral vectors, their tropism frequently does not match the therapeutic need. In the past, this lack of appropriate targeting allowed only partial exploitation of the great potential of gene therapy. Substantial progress in modifying viral vectors using diverse techniques now allows targeting to many cell types in vitro. Although important challenges remain for in vivo applications, the first clinical trials with targeted vectors have already begun to take place.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Genetic Engineering / methods*
  • Genetic Engineering / trends
  • Genetic Therapy / methods*
  • Genetic Therapy / trends
  • Genetic Vectors*
  • Humans
  • In Vitro Techniques
  • Ligands
  • Models, Genetic
  • Transduction, Genetic
  • Viruses / genetics*


  • Ligands